PPBTNasdaqPharmaceutical PreparationsFiscal year ends December 31
PURPLE BIOTECH LTD.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 19, 2026
$1.08−0.06 (-5.26%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 40.0
- Dividend yield
- –
Share price
−$5.00 (−82.23%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsSplit
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Dec 31, 2025
Valuation
- Market cap
- –
- P/E ratio
- 40.0
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$26.39M
- EPS, diluted
- $0.03
- Free cash flow
- -$5.66M
Twelve years at a glance
Fiscal years 2014 to 2025, USD
Revenue
–
Operating income
–
Net income
-$26.39M
EPS, diluted
$0.03-99.5% YoY
Free cash flow
-$5.66M
Reported period